What is SOLV's market cap?

$15.21B, based on the Nov 4 close of $89.35.

What is SOLV's P/E ratio?

10.6× trailing-twelve-month earnings of $1.43B.

Does Solventum pay a dividend?

No regular cash dividend has been paid in the last year.

How much of SOLV is sold short?

5.0M shares, 3.4% of float, as of Oct 15, 2026.

What sector is SOLV in?

Healthcare, in the Surgical Instruments industry.

NYSE · SOLVHealthcareSurgical Instruments

Solventum Corporation (SOLV)

$89.35+5.42%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$90.12▲ 32.30% in range

Nov 3, 2025Low $62.49 · High $92.44Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Solventum closed at $89.35 on Nov 4, up 5.42%, 3.3% below its 52-week closing high. Volume of 2.2M shares was 1.95× its 20-day average (above normal).

Split-adjusted performance: +2.7% over one month, +25.9% over six months, +31.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $2.21B, up 2.2% from a year earlier, with a net margin of 4.2%.

Short interest was 5.0M shares at the Oct 15 settlement, up 1.2% from the prior report (3.4% of float, 4.7 days to cover).

Market cap$15.21B170.2M shares

Revenue · quarter$2.21B+2.2% YoY

Diluted EPS$0.53+3.9% YoY

P/E · TTM10.6×P/S 1.8×

Net margin4.2%Gross 58.2%

Dividend yieldNone

52-week range62.49 – 92.44−3.3% from high

Volume2.2M1.95× 20-day avg

Volatility · 60d24.8%Annualised

Short % of float3.4%4.7 days to cover

Net cash-$4.88BCash $403.0M

Next earnings—Not scheduled

Split-adjusted performance

1W +9.2%1M +2.7%3M +7.7%6M +25.9%YTD +12.8%1Y +31.2%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum70

Revenue growth30

Net margin68

Value (low P/E)87

Size93

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short5.0M+1.2% vs prior

Days to cover4.7Settled Oct 15

% of float3.4%

Short vol. 10d52.5%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
SOLVSolventum	$89.35	+5.42%	+25.9%	+2.2%	4.2%	10.6	$15.21B
GKOSGlaukos	$246.70	+5.86%	+82.4%	+58.0%	1.0%	—	$14.60B	Compare
BAXBaxter International	$26.50	+3.96%	+56.1%	+5.0%	9.9%	—	$13.71B	Compare
PENPenumbra	$322.45	+0.76%	−0.5%	+15.6%	10.3%	80.9	$12.71B	Compare
GMEDGLOBUS MEDICAL	$87.10	+9.45%	−2.4%	+5.9%	19.2%	21.8	$11.69B	Compare
PODDInsulet	$165.02	+6.56%	+9.1%	+23.5%	11.8%	30.5	$11.44B	Compare
WSTWest Pharmaceutical Services	$408.78	+0.44%	+30.8%	+8.7%	24.5%	44.6	$28.48B	Compare
DXCMDexCom	$88.48	+6.64%	+46.6%	+11.2%	20.5%	33.3	$33.00B	Compare
RMDResMed	$240.51	+5.91%	+14.7%	+5.9%	29.6%	21.2	$33.83B	Compare

News about Solventum

All news →

SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds?Zacks Investment Research · 2d agoNeutral Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research · 6d ago▲ Positive SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapyZacks Investment Research · Oct 23, 2026▲ Positive Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?Zacks Investment Research · Oct 8, 2026▲ Positive Why Solventum (SOLV) is a Top Value Stock for the Long-TermZacks Investment Research · Oct 8, 2026▲ Positive

Quick answers

What does Solventum do?: In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments.
What is SOLV's market cap?: $15.21B, based on the Nov 4 close of $89.35.
What is SOLV's P/E ratio?: 10.6× trailing-twelve-month earnings of $1.43B.
Does Solventum pay a dividend?: No regular cash dividend has been paid in the last year.
How much of SOLV is sold short?: 5.0M shares, 3.4% of float, as of Oct 15, 2026.
What sector is SOLV in?: Healthcare, in the Surgical Instruments industry.

About Solventum

In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.

HQ: Eagan, MN20,000 employeesListed Mar 26, 2024solventum.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology